FP7H2020
Pharma Mar SA
- Country
- ESSpain
- Defence projects
- 0
- Projects, all programmes
- 13
- As coordinator
- 0
- EU contribution (CORDIS)
- EUR 2,554,798
- Active
- 2008 to 2021
Projects
13 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| SECRETedSustainable Exploitation of bio-based Compounds Revealed and Engineered from naTural sources. | H2020 | 2021 | Participant | EUR 334,730 |
| ITCC-P4ITCC Pediatric Preclinical POC Platform – Sofia ref.: 116064 | H2020 | 2017 | Participant | EUR 0 |
| INMAREIndustrial Applications of Marine Enzymes: Innovative screening and expression platforms to discover and use the functional protein diversity from the sea | H2020 | 2015 | Participant | EUR 249,460 |
| ProteinConjugatesA training network for the chemical site-selective modification of proteins: Preparation of the next-generation of therapeutic chemically-defined protein conjugates | H2020 | 2015 | Partner | EUR 0 |
| BLUEPHARMTRAINBluePharmTrain | FP7 | 2013 | Participant | EUR 200,684 |
| MACUMBAMarine Microorganisms: Cultivation Methods for Improving their Biotechnological Applications | FP7 | 2012 | Participant | EUR 281,016 |
| MICRO B3Marine Microbial Biodiversity, Bioinformatics and Biotechnology | FP7 | 2012 | Participant | EUR 204,485 |
| OPTATIOOPtimizing TArgets and Therapeutics In high risk and refractOry Multiple Myeloma | FP7 | 2012 | Participant | EUR 239,880 |
| MULTIFUNMultifunctional Nanotechnology for selective detection and Treatment of cancer | FP7 | 2011 | Participant | EUR 219,912 |
| MAMBAMarine Metagenomics for New Biotechnological Applications | FP7 | 2009 | Participant | EUR 50,000 |
| METAFIGHTUnderstanding and fighting metastasis via dissection of the Core Invasive Machinery | FP7 | 2008 | Participant | EUR 154,234 |
| DENDREAMERSFunctional liquid Crystalline dendrimers: Synthesis of New Materials, Resource for New Applications | FP7 | 2008 | Participant | EUR 288,017 |
| NANOTHERIntegration of Novel Nanoparticle based Technology for Therapeutics and Diagnosis of different types of Cancer | FP7 | 2008 | Participant | EUR 332,381 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.